Cookies?
Library Header Image
LSE Research Online LSE Library Services

Rethinking the appraisal and approval of drugs for type 2 diabetes

Naci, Huseyin, Lehman, Richard, Wouters, Olivier J., Goldacre, Ben and Yudkin, John S (2015) Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ, 351 (h5260). ISSN 1756-1833

[img]
Preview
PDF - Accepted Version
Download (552kB) | Preview

Identification Number: 10.1136/bmj.h5260

Abstract

The process for approving new drugs for type 2 diabetes illustrates the significant shortcomings of the regulatory standards for licensing, reimbursing, and adopting new drugs. Regulatory reform is needed to improve the real-world therapeutic value of anti-diabetic drugs.

Item Type: Article
Official URL: http://www.bmj.com/
Additional Information: © 2015 BMJ Publishing Group Ltd
Divisions: LSE Health
Subjects: R Medicine > RA Public aspects of medicine
Sets: Research centres and groups > LSE Health and Social Care
Research centres and groups > LSE Health
Date Deposited: 22 Oct 2015 14:03
Last Modified: 20 Sep 2019 02:02
URI: http://eprints.lse.ac.uk/id/eprint/64115

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics